Broadfin Capital as of Sept. 30, 2017
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 43 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Heron Therapeutics (HRTX) | 8.3 | $56M | 3.5M | 16.15 | |
| Corium Intl | 7.3 | $49M | 4.4M | 11.08 | |
| Retrophin | 6.3 | $43M | 1.7M | 24.89 | |
| Horizon Pharma | 5.8 | $39M | 3.1M | 12.68 | |
| Flamel Technologies Sa (AVDL) | 5.5 | $38M | 3.6M | 10.50 | |
| La Jolla Pharmaceuticl Com Par | 5.4 | $37M | 1.1M | 34.78 | |
| Aratana Therapeutics | 4.7 | $32M | 5.2M | 6.13 | |
| AngioDynamics (ANGO) | 4.5 | $30M | 1.8M | 17.09 | |
| Zimmer Holdings (ZBH) | 4.3 | $29M | 249k | 117.08 | |
| Mirati Therapeutics | 4.3 | $29M | 2.5M | 11.70 | |
| Recro Pharma (SCTL) | 4.1 | $28M | 3.1M | 8.98 | |
| Endo International (ENDPQ) | 3.8 | $26M | 3.0M | 8.57 | |
| Strongbridge Bioph shs usd | 3.0 | $20M | 2.9M | 6.90 | |
| Iovance Biotherapeutics (IOVA) | 2.9 | $19M | 2.5M | 7.75 | |
| Ignyta | 2.7 | $19M | 1.5M | 12.35 | |
| Catalyst Pharmaceutical Partners (CPRX) | 2.6 | $17M | 6.9M | 2.52 | |
| Noveliontherapeuti.. | 2.0 | $14M | 1.9M | 7.03 | |
| BioDelivery Sciences International | 1.9 | $13M | 4.4M | 2.95 | |
| Antares Pharma | 1.5 | $10M | 3.2M | 3.24 | |
| Aerie Pharmaceuticals | 1.5 | $10M | 215k | 48.60 | |
| Paratek Pharmaceuticals | 1.5 | $10M | 406k | 25.10 | |
| Teligent | 1.4 | $9.6M | 1.4M | 6.71 | |
| Veracyte (VCYT) | 1.3 | $9.0M | 1.0M | 8.77 | |
| Alnylam Pharmaceuticals (ALNY) | 1.3 | $8.7M | 74k | 117.49 | |
| Natus Medical | 1.1 | $7.7M | 204k | 37.50 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 1.0 | $6.6M | 820k | 8.10 | |
| Tetraphase Pharmaceuticals | 0.9 | $6.2M | 900k | 6.84 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.9 | $6.0M | 15M | 0.40 | |
| Amarin Corporation (AMRN) | 0.8 | $5.7M | 1.6M | 3.50 | |
| Idera Pharmaceuticals | 0.8 | $5.4M | 2.4M | 2.23 | |
| Regulus Therapeutics | 0.8 | $5.4M | 4.3M | 1.25 | |
| Zogenix | 0.7 | $4.9M | 141k | 35.05 | |
| NuVasive | 0.7 | $4.9M | 88k | 55.45 | |
| Egalet Corporation note 5.50% 4/1/20 | 0.7 | $4.8M | 10M | 0.48 | |
| Baxter International (BAX) | 0.6 | $4.1M | 65k | 62.76 | |
| Integra LifeSciences Holdings (IART) | 0.6 | $4.0M | 79k | 50.48 | |
| Owens & Minor (OMI) | 0.6 | $3.9M | 134k | 29.20 | |
| Contrafect | 0.5 | $3.0M | 2.7M | 1.11 | |
| Mediwound Ltd cmn | 0.4 | $2.7M | 500k | 5.35 | |
| Cogentix Medical | 0.4 | $2.6M | 1.0M | 2.56 | |
| Amicus Therapeutics (FOLD) | 0.3 | $2.1M | 141k | 15.08 | |
| Ovascience | 0.1 | $781k | 550k | 1.42 | |
| Strata Skin Sciences (SSKN) | 0.0 | $85k | 48k | 1.78 |
